Characterization of the effect of interleukin-10 on silica-induced lung fibrosis in mice

Am J Respir Cell Mol Biol. 2004 Jul;31(1):78-85. doi: 10.1165/rcmb.2003-0299OC. Epub 2004 Feb 19.

Abstract

We previously described a reduction of silica-induced lung fibrosis in interleukin-10-deficient mice (IL-10-/-) (Huaux and colleagues; Am. J. Respir. Cell Mol. Biol. 1998;18:51-59). In the present study, we further dissect the exact functions of IL-10 in experimental silicosis. The reduced lung fibrotic response to silica in IL-10-/- mice was accompanied by a marked recruitment of TH1 CD4+ lymphocytes. However, treatment with anti-CD4 antibodies reduced silica-induced lung fibrosis in both IL-10-/- and IL-10+/+ mice, suggesting that this T cell population actually contributes to the extension of the fibrotic lesions in a manner that is independent of IL-10. In IL-10-/- mice, silica-induced lung production of the profibrotic mediator transforming growth factor (TGF)-beta1 and the antifibrotic eicosanoid PGE2 were reduced and increased, respectively, relative to that in IL-10+/+ mice. In addition, in vitro experiments indicated that recombinant IL-10 upregulated TGF-beta1 expression in alveolar macrophages while in contrast it downregulated PGE2 production and cyclooxygenase-2 expression in both lung fibroblasts and macrophages. Thus the net profibrotic activity of IL-10 in vivo appears to be mediated by its ability to stimulate the expression of the profibrotic cytokine TGF-beta1 while suppressing the expression of cyclooxygenase-2 and thus production of the antifibrotic eicosanoid PGE2. These effects appear to be independent of the enhanced lung CD4+ T-lymphocytosis observed in IL-10-deficient mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies / pharmacology
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / immunology
  • Chemotaxis, Leukocyte / drug effects
  • Chemotaxis, Leukocyte / immunology
  • Cyclooxygenase 2
  • Dinoprostone / metabolism
  • Disease Models, Animal
  • Down-Regulation / drug effects
  • Down-Regulation / physiology
  • Female
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism
  • Interleukin-10 / deficiency
  • Interleukin-10 / genetics*
  • Isoenzymes / drug effects
  • Isoenzymes / genetics
  • Isoenzymes / metabolism
  • Lung / drug effects
  • Lung / immunology*
  • Lung / physiopathology
  • Macrophages / drug effects
  • Macrophages / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Prostaglandin-Endoperoxide Synthases / drug effects
  • Prostaglandin-Endoperoxide Synthases / genetics
  • Prostaglandin-Endoperoxide Synthases / metabolism
  • Pulmonary Fibrosis / chemically induced
  • Pulmonary Fibrosis / genetics*
  • Pulmonary Fibrosis / immunology*
  • RNA, Messenger / drug effects
  • RNA, Messenger / metabolism
  • Receptors, Interleukin / drug effects
  • Receptors, Interleukin / metabolism
  • Receptors, Interleukin-10
  • Silicon Dioxide*
  • Th1 Cells / drug effects
  • Th1 Cells / immunology
  • Transforming Growth Factor beta / drug effects
  • Transforming Growth Factor beta / genetics
  • Transforming Growth Factor beta / metabolism
  • Transforming Growth Factor beta1

Substances

  • Antibodies
  • Isoenzymes
  • RNA, Messenger
  • Receptors, Interleukin
  • Receptors, Interleukin-10
  • Tgfb1 protein, mouse
  • Transforming Growth Factor beta
  • Transforming Growth Factor beta1
  • Interleukin-10
  • Silicon Dioxide
  • Cyclooxygenase 2
  • Prostaglandin-Endoperoxide Synthases
  • Dinoprostone